Hematology-Oncology Program Investigator Joshua D. Brandstadter received the Doris Duke Physician-Scientist Fellowship Award. The $220,000 award is given to physician scientists at the subspecialty fellowship level who seek to conduct additional years of research with the goal of assisting in the transition to a research faculty position.
This award will support Dr. Brandstadter’s work on Castleman’s disease, a rare inflammatory disease that causes large lymph nodes and life-threatening inflammation throughout the body.
Timothy Brown, innovation researcher at the Penn Center for Cancer Care Innovation (PC3I) and principal investigator in hematology-oncology, has been named the recipient of the Conquer Cancer 2022 ASCO Annual Meeting Merit Award, given to trainees who are first authors of selected abstracts for presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting.
Jennifer R. Eads, Associate Professor of Clinical Medicine and GI Clinical Research Physician, received the Young Investigator of the Year Award from the ECOG-ACRIN Cancer Research Group.
This award, funded by the ECOG Research and Education Foundation, recognizes extraordinary scientific achievements and contributions to the direction of research made by researchers during the early years of their careers (under 46). ).
Dr. Eads is also Director of the Neuroendocrine Tumor Program.
Alexander C. Huang, Assistant Professor of Hematology-Oncology, received the 2022 Melanoma Research Foundation Breakthrough Consortium (MRFBC) Young Investigator Research Team Award, a two-year award with a total prize of $300,000, funded by a grant from Bristol Myers Squibb, to advance the field of translational immuno-oncology.
The goal of this award is to help identify and support the next generation of melanoma scientists to focus on either improving clinical outcomes for melanoma patients treated with immuno-oncology agents or advancing the scientific understanding of immuno-oncology and the role of the immune system. system in melanoma.
Steven Kawut, Professor of Medicine and Epidemiology and Director of the Pulmonary Hypertension (PH)/Pulmonary Vascular Disease Program, received the Pulmonary Hypertension Association (PHA) Outstanding Physician Award at the International Scientific Conference and Sessions PHA 2022. The award recognizes Dr. Kawut as a leader in promoting excellent clinical care, research, education and advocacy for PH patients.
Dr. Kawut has published over 300 papers and is currently funded by the National Institutes of Health to conduct clinical trials and physical activity studies in people with pulmonary hypertension.
Bonnie Ky, associate professor of cardiovascular medicine and epidemiology and director of the Penn Cardio-Oncology Translational Center of Excellence, has been included by Cancer Health magazine in the Cancer Health 25, an annual list that honors people who have made a difference in the lives of people with cancer. Dr. Ky has been a leading force in the development of cardio-oncology, which focuses on the detection, monitoring and treatment of cardiovascular disease before, during and after cancer treatment.
Anne Marie McCarthy, Assistant Professor of Epidemiology, has received $50,000 from the Pennsylvania Breast Cancer Coalition to support her research in cancer epidemiology with a focus on reducing breast cancer disparities by developing breast cancer screening strategies. precision. Dr. McCarthy’s work builds on a growing understanding of breast cancer biology and risk by focusing on a key clinical concern: identifying women who are at high risk for aggressive and potentially go undetected during mammography screening and who could benefit from further screening treatment.
Sarah Skuli, a third-year hematology-oncology fellow, has been selected by the American Society of Hematology (ASH) as one of 16 outstanding fellows to receive the 2022 ASH Research Training Award for Fellows (RTAF), a program of year encourage careers in academic hematology by providing protected research time during training. Each RTAF Fellow will receive $70,000 to support a hematology research project for the duration of the program. Dr. Skuli’s area of interest is the highly aggressive and rapidly fatal subtype of acute myeloid leukemia (AML) that harbors inactivating mutations in a key leukemia cell growth suppressor, TP53. Dr. Skuli is working to understand the role that cellular metabolism and cholesterol synthesis play in enabling this subtype of AML to resist current chemotherapies in order to identify new therapies to treat patients suffering from this cancer of the brain. blood.
Hongjun Song, Professor of Neuroscience, and Brian Litt, Professor of Neurology and Bioengineering and Director of the Penn Epilepsy Center, received the 2022 Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS). The award honors Drs. Song and Litt for their dedication to top quality mentorship and training in the field of neuroscience research. They will each receive $100,000 as a supplement to an existing NINDS grant to support their efforts to foster the career advancement of additional trainees.